Table 2.
Sex | Risk Factor Reported 6 Months Prior to Reinfection | First Positive HCV RNA Value After SVR | Genotype at Baseline | Genotype at Reinfection | Time from SVR to Reinfection (days) | Number of RNA Measures Before/ After Reinfection | Average Time Between Measures (days) | HCV RNA (copies/ mL) Values Post- Reinfection | |
---|---|---|---|---|---|---|---|---|---|
1 | Male | Low-risk MSM, high-frequency IDU |
90000 | 1 | Not tested | 1281 | 7/1 | 183 | Subsequent visit undetectable |
2 | Male | None reported | Detectable (qualitative) | 2b | 3a | 259 | 2/4 | 259 | All subsequent visits detectable >3 000 000 |
3 | Male | High-frequency IDU | 126000 | 2 | 1a | 925 | 4/5 | 308 | All subsequent visits detectable > 1 000 000 |
4 | Male | High-risk MSM | Detectable (qualitative) | 1a | 3a | 573 | 4/12 | 191 | All subsequent visits detectable (qualitative) |
5 | Male | High-risk MSM | Detectable (qualitative) | 1a | 3a | 370 | 3/1 | 185 | Subsequent visit detectable (qualitative) |
6 | Male | Low-risk MSM | Detectable (qualitative) | 3a | 1 | 698 | 2/2 | 698 | All subsequent visits detectable > 900 000 |
7 | Female | High-frequency IDU | Detectable (qualitative) | 1a | 3a | 1297 | 8/2 | 185 | All subsequent visits detectable (qualitative) |
8 | Male | High-frequency IDU | Detectable (qualitative) | 2b | 1a | 1309 | 6/4 | 262 | All subsequent visits detectable (qualitative) |
9 | Male | High-frequency IDU | Detectable (qualitative) | 3a | Not tested | 1115 | 4/1 | 372 | Subsequent visit undetectable |
10 | Male | High-risk MSM | Detectable (qualitative) | 1a | Not tested | 1088 | 7/4 | 181 | All subsequent visits undetectable |
11 | Male | High-frequency IDU | 26000 | 3a | 1a | 548 | 2/2 | 274 | Subsequent visits detectable > 26100 |
12 | Female | None reported | 1400000 | 3a | 1 | 719 | 3/1 | 360 | Subsequent visit detectable at 5 000 000 |
13 | Male | None reported | Detectable (qualitative) | 3 | 3a | 350 | 3/1 | 175 | Subsequent visit detectable at 9000 |
14 | Male | Low-risk MSM | 27000 | 1a | 1a | 1167 | 6/2 | 233 | All subsequent visits detectable > 242000 |
15 | Male | None reported | Detectable (qualitative) | 3a | Not tested | 169 | 2/1 | 169 | Subsequent visit undetectable |
16 | Male | Low-frequency IDU | 178 | Unknown | 3a | 1063 | 6/1 | 213 | Subsequent visit undetectable |
17 | Male | High-frequency IDU | 412000 | 1a | 1a | 1396 | 5/1 | 349 | Subsequent visit detectable at 1500 |
18 | Male | High-frequency IDU | 531000 | 1a | 1a | 549 | 2/1 | 549 | Subsequent visit detectable at 322000 |
Abbreviations: HCV, hepatitis C virus; IDU, injection drug use; MSM, men who have sex with men; SVR, sustained virologic response.